Neuroscience Antibodies & Assays Market Booming by Size, Revenue, Trend and Top Growing Companies 2026 – Vital News 24

Neuroscience Antibodies & Assays Market

New Jersey, United States, The report offers an all-inclusive and accurate research study on the Neuroscience Antibodies & Assays Market while chiefly that specialize in current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly have the benefit of the thorough marketing research provided within the report. The authors of the report have compiled an in depth study on crucial market dynamics, including growth drivers, restraints, and opportunities. This study will help market participants to induce a decent understanding of future development of the Neuroscience Antibodies & Assays market. The report also focuses on market taxonomy, regional analysis, opportunity assessment, and vendor analysis to assist with comprehensive evaluation of the Neuroscience Antibodies & Assays market.

Neuroscience Antibodies & Assays Market was valued at USD 2.42 Billion in 2018 and is projected to reach USD 5.14 Billion by 2026, growing at a CAGR of 9.7% from 2019 to 2026.

Request a Sample Copy of this report @https://www.verifiedmarketresearch.com/download-sample/?rid=28342&utm_source=VN24&utm_medium=002

Top 10 Companies in the Global Neuroscience Antibodies & Assays Market Research Report:

Global Neuroscience Antibodies & Assays Market: Competitive Landscape

The research analysts who have authored this report are experts in performing competitive analysis of the global Neuroscience Antibodies & Assays market. They have deeply profiled leading as well as other players of the global Neuroscience Antibodies & Assays market with large emphasis on their market share, recent developments, business overview, markets served, and growth strategies. The report not only provides valuable insights into the competitive landscape but also concentrates on minor as well as major factors influencing the business of players. The product portfolios of all companies profiled in the report are compared in quite some detail in the product analysis section.

Global Neuroscience Antibodies & Assays Market: Segment Analysis

The global Neuroscience Antibodies & Assays market is segmented according to type, application, and region. The analysts have carefully studied each segment and sub-segment to provide a broad segmental analysis of the global Neuroscience Antibodies & Assays market. The segmentation study identifies leading segments and explains key factors supporting their growth in the global Neuroscience Antibodies & Assays market. In the regional analysis section, the report authors have shown how different regions and countries are growing in the global Neuroscience Antibodies & Assays market and have predicted their market sizes for the next few years. The segmental analysis will help companies to focus on high-growth areas of the global Neuroscience Antibodies & Assays market.

Global Neuroscience Antibodies & Assays Market: Regional Analysis

This part of the report includes detailed information of the market in different regions. Each region offers different scope to the market as each region has different government policy and other factors. The regions included in the report are North America, South America, Europe, Asia Pacific, and the Middle East. Information about different region helps the reader to understand global market better.

Ask for Discount @https://www.verifiedmarketresearch.com/ask-for-discount/?rid=28342&utm_source=VN24&utm_medium=002

Table of Content

1 Introduction of Neuroscience Antibodies & Assays Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Neuroscience Antibodies & Assays Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Neuroscience Antibodies & Assays Market, By Deployment Model

5.1 Overview

6 Neuroscience Antibodies & Assays Market, By Solution

6.1 Overview

7 Neuroscience Antibodies & Assays Market, By Vertical

7.1 Overview

8 Neuroscience Antibodies & Assays Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Neuroscience Antibodies & Assays Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Request Customization of Report @ https://www.verifiedmarketresearch.com/product/Neuroscience-Antibodies-&-Assays-Market/?utm_source=VN24&utm_medium=002

Highlights of Report

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne Fernandes Call: +1 (650) 781 4080 Email: [emailprotected]

See the original post here:
Neuroscience Antibodies & Assays Market Booming by Size, Revenue, Trend and Top Growing Companies 2026 - Vital News 24

Neuroscience Antibodies and Assays Market to Register a Healthy CAGR Throughout 20172025 – Fusion Science Academy

The Hiv Therapeutics Market research report added by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.

The Hiv Therapeutics market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Hiv Therapeutics market and the trends that will prevail in this industry.

Request Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2423424&source=atm

What pointers are covered in the Hiv Therapeutics market research study?

The Hiv Therapeutics market report Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Hiv Therapeutics market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Hiv Therapeutics market report Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

* Boehringer Ingelheim International GmbH* Merck & Co.* ViiV Healthcare* AbbVie* F. Hoffmann-La Roche Ltd.* Teva Pharmaceutical Industries Ltd.For complete companies list, please ask for sample pages.

The information for * Company Profile* Main Business Information * SWOT Analysis * Sales, Revenue, Price and Gross Margin * Market Share

For product type segment, this report listed main product type of Hiv Therapeutics market* Product Type I* Product Type II* Product Type III

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.* Hospitals* Clinics* Labs

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:* North America* South America* Asia & Pacific* Europe* MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Make An EnquiryAbout This Report @ https://www.marketresearchhub.com/enquiry.php?type=E&repid=2423424&source=atm

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Hiv Therapeutics market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Hiv Therapeutics market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The Hiv Therapeutics market report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2423424&licType=S&source=atm

Some of the Major Highlights of TOC covers:

Read the original post:
Neuroscience Antibodies and Assays Market to Register a Healthy CAGR Throughout 20172025 - Fusion Science Academy

Inscopix Real-Time Brain Mapping Technology Empowers More Than 100 Scientific Publications – Business Wire

PALO ALTO, Calif.--(BUSINESS WIRE)--Inscopix celebrates an important milestone that neuroscientists across the world using the companys brain mapping platform have collectively achieved more than 100 scientific publications that shed light on how brain circuits shape behavior and cognition, both in health and in disease.

Used by over 400 academic and industry laboratories, Inscopixs miniature microscope-based brain mapping technology enables the recording and manipulation of brain activity in thousands of neurons simultaneously in freely behaving animal subjects. This unprecedented experimental capability, bolstered by a complete solution from biological reagents to data analytics to world class scientific support, has enabled key neuroscience discoveries in areas including learning and memory, sleep, and social behavior. Some of these insights have already been leveraged in translational research for many difficult-to-treat indications, including Parkinsons disease and chronic pain.

We are really proud of the amazing research that our customers and collaborators worldwide are pioneering. To know that our platform and solutions have helped enable more than 100 publications since the first shipment of our nVista product in 2013, is extremely rewarding and inspiring, said Kunal Ghosh, Ph.D., founder and CEO of Inscopix. We are committed to our customers scientific success and we look forward to helping them catalyze new breakthroughs in our mechanistic understanding of the brain.

Inscopix will continue to celebrate this milestone throughout 2020. Congratulate the community of researchers and take part in spreading awareness about their research by following us on Facebook, LinkedIn, Instagram, YouTube and Twitter. To learn more about the technology and our recent research collaborations, visit: https://www.inscopix.com/.

About nVista and nVoke systems

nVista and nVoke systems are Inscopixs state-of-the-art miniature microscope-based solution for imaging and manipulation of large-scale neural circuit dynamics in freely behaving subjects. With nVista and nVoke, researchers at leading research institutions worldwide are pushing the frontiers of neuroscience and asking entirely new questions about how neural circuits shape cognition and behavior in health and disease. For more information, please visit: https://www.inscopix.com/nVoke.

About Inscopix, Inc.

Inscopix empowers the development of next-generation therapeutics for difficult-to-treat brain disorders by enabling innovative research and predictive preclinical therapeutic development. Driven by a North Star of overcoming historic challenges in the field, Inscopix provides validated solutions for real-time mapping of neural activity in brain circuits. These objective, quantitative and in-brain assays are catalyzing unprecedented insights into disease mechanisms and have been shown to be more accurate at predicting clinical efficacy than animal behavior when testing a therapeutic candidates capacity to bring the brain back to a normal state. Inscopixs partner and customer discoveries help decode the brain, inform deeper understanding of mechanisms of action and enable the screening of drugs based on efficacy. For more information, please visit http://www.inscopix.com.

See the original post here:
Inscopix Real-Time Brain Mapping Technology Empowers More Than 100 Scientific Publications - Business Wire

Alzheimer disease Symptoms are located in Biomarks and Research in Cognitive Neuroscience has found that! – Gizmo Posts 24

Researchers have marked a new research study in understanding and detecting the complex disease- Alzheimers. They have located a biomarker.

The research team belongs to the Complutense University of Madrid (UCM). M Eugenia Lpez Garca, the author of the research study and researcher from the Cognitive Neuroscience group of the UCM, said that with this research they work on finding two subnets in the form of theta and beta frequency bands and involving frontotemporal and frontal occipital regions, that are altered during evolution of Alzheimers Disease.

The research journal was published in Brain, and the theme is about the hyper synchronization and increased connectivity between brain regions, which is the main axis of changes and magnetoencephalography (MEG) as the tools used to detect it.

The research shows that patients suffering through Mild Cognitive Impairment (MCI) afterward develop Alzheimers Disease have an increase in synchronization, but as dementia starts to develop, the synchrony starts to decrease as a symptom of cortical network dysfunction.

For the research process, 54 patients having Mild Cognitive Impairment (MCI) were recruited and monitored every six months consecutively for a time span of three years. The researchers implemented magnetoencephalography records to measure the magnetic fields of the brain at the pre-phase, which is the beginning and the post phase, which the end of the study.

The biomarker is believed to help in understanding the terrible disease and making a discovery to improve knowledge about the complexity of the disease.

View post:
Alzheimer disease Symptoms are located in Biomarks and Research in Cognitive Neuroscience has found that! - Gizmo Posts 24

What are the laws for sperm donation in the UK? – The Independent

A recent report published in the Journal of Medical Ethics has argued that doctors should be able to take sperm from men who have passed away if they have consented to becoming post-mortem donors.

The authors state that doing so is both feasible and morally permissible, as it may help to ensure that sufficient quantities of sperm are made available to individuals who wish to become parents through sperm donation.

So where does the law in the UK currently stand with regards to sperm donation? Here is everything you need to know.

Sharing the full story, not just the headlines

According to the Human Fertilisation and Embryology Authority (HFEA), sperm donors are usually aged between 18 and 41.

Thousands of 999 patients in England are being told to get a taxi to hospital, figures have showed. The number of patients outside London who were refused an ambulance rose by 83 per cent in the past year as demand for services grows

Getty

A vaping-related lung disease has claimed the lives of 11 people in the US in recent weeks. The US Centre for Disease Control and Prevention has more than 100 officials investigating the cause of the mystery illness, and has warned citizens against smoking e-cigarette products until more is known, particularly if modified or bought off the street

Getty

Researchers in the US claim to have overcome one of the major hurdles to cultivating human follicles from stem cells. The new system allows cells to grow in a structured tuft and emerge from the skin

Sanford Burnham Preybs

A study in the journal Scientific Reports suggests that a dose of nature of just two hours a week is associated with better health and psychological wellbeing

Shutterstock

Exposure to air from traffic-clogged streets could leave women with fewer years to have children, a study has found. Italian researchers found women living in the most polluted areas were three times more likely to show signs they were running low on eggs than those who lived in cleaner surroundings, potentially triggering an earlier menopause

Getty/iStock

Junk food adverts on TV and online could be banned before 9pm as part of Government plans to fight the "epidemic" of childhood obesity.Plans for the new watershed have been put out for public consultation in a bid to combat the growing crisis, the Department of Health and Social Care (DHSC) said

PA

On migrating from Africa around 70,000 years ago, humans bumped into the neanderthals of Eurasia. While humans were weak to the diseases of the new lands, breeding with the resident neanderthals made for a better equipped immune system

PA

The breath biopsy device is designed to detect cancer hallmarks in molecules exhaled by patients

Getty

By their 10th birthdy, children have on average already eaten more sugar than the recommended amount for an 18 year old. The average 10 year old consumes the equivalent to 13 sugar cubes a day, 8 more than is recommended

PA

While there is not enough evidence of harm to recommend UK-wide limits on screen use, the Royal College of Paediatrics and Child Health have advised that children should avoid screens for an hour before bed time to avoid disrupting their sleep

Getty

A study published in the New England Journal of Medicine has found that many elderly people are taking daily aspirin to little or no avail

Getty

A study by the University of Minnesota's Masonic Cancer Centre has found that the carcinogenic chemicals formaldehyde, acrolein, and methylglyoxal are present in the saliva of E-cigarette users

Reuters

There has been a 41% increase in children with type 2 diabetes since 2014, the National Paediatric Diabetes Audit has found. Obesity is a leading cause

Reuters

The majority of antidepressants are ineffective and may be unsafe, for children and teenager with major depression, experts have warned. In what is the most comprehensive comparison of 14 commonly prescribed antidepressant drugs to date, researchers found that only one brand was more effective at relieving symptoms of depression than a placebo. Another popular drug, venlafaxine, was shown increase the risk users engaging in suicidal thoughts and attempts at suicide

Getty

Researchers at the Baptist Health South Florida Clinic in Miami focused on seven areas of controllable heart health and found these minority groups were particularly likely to be smokers and to have poorly controlled blood sugar

iStock

A major pressure group has issued a fresh warning about perilously high amounts of sugar in breakfast cereals, specifically those designed for children, and has said that levels have barely been cut at all in the last two and a half decades

Getty

New guidance by the National Institute for Health and Care Excellence (NICE), the body which determines what treatment the NHS should fund, said lax road repairs and car-dominated streets were contributing to the obesity epidemic by preventing members of the public from keeping active

PA

A new class of treatments for women going through the menopause is able to reduce numbers of debilitating hot flushes by as much as three quarters in a matter of days, a trial has found.The drug used in the trial belongs to a group known as NKB antagonists (blockers), which were developed as a treatment for schizophrenia but have been sitting on a shelf unused, according to Professor Waljit Dhillo, a professor of endocrinology and metabolism

REX

Research from Oxford University found that more than one million extra people suffering from mental health problems would benefit from being prescribed drugs and criticised ideological reasons doctors use to avoid doing so.

Getty

The family of a teenager who died from flu has urged people not to delay going to A&E if they are worried about their symptoms. Melissa Whiteley, an 18-year-old engineering student from Hanford in Stoke-on-Trent, fell ill at Christmas and died in hospital a month later.

Just Giving

The Government has pledged to review tens of thousands of cases where women have been given harmful vaginal mesh implants.

Getty

The NHS will be asked to go further to prevent the deaths of patients in its care as part of a zero suicide ambition being launched today

Getty

Human trials have begun with a new cancer therapy that can prime the immune system to eradicate tumours. The treatment, that works similarly to a vaccine, is a combination of two existing drugs, of which tiny amounts are injected into the solid bulk of a tumour.

Nephron

Mothers living within a kilometre of a fracking site were 25 per cent more likely to have a child born at low birth weight, which increase their chances of asthma, ADHD and other issues

Getty

Thousands of cervical cancer screening results are under review after failings at a laboratory meant some women were incorrectly given the all-clear. A number of women have already been told to contact their doctors following the identification of procedural issues in the service provided by Pathology First Laboratory.

Rex

Most breast cancer patients do not die from their initial tumour, but from secondary malignant growths (metastases), where cancer cells are able to enter the blood and survive to invade new sites. Asparagine, a molecule named after asparagus where it was first identified in high quantities, has now been shown to be an essential ingredient for tumour cells to gain these migratory properties.

Getty

A record number of nursing and midwifery positions are currently being advertised by the NHS, with more than 34,000 positions currently vacant, according to the latest data. Demand for nurses was 19 per cent higher between July and September 2017 than the same period two years ago.

REX

CBD has a broadly opposite effect to delta-9-tetrahydrocannabinol (THC), the main active component in cannabis and the substance that causes paranoia and anxiety.

Getty

Mr Bransons company sued the NHS last year after it lost out on an 82m contract to provide childrens health services across Surrey, citing concerns over serious flaws in the way the contract was awarded

PA

The numbers of people accepted to study nursing in England fell 3 per cent in 2017, while the numbers accepted in Wales and Scotland, where the bursaries were kept, increased 8.4 per cent and 8 per cent respectively

Getty

The paper found that there were 45,000 more deaths in the first four years of Tory-led efficiencies than would have been expected if funding had stayed at pre-election levels.On this trajectory that could rise to nearly 200,000 excess deaths by the end of 2020, even with the extra funding that has been earmarked for public sector services this year.

Reuters

Hours of commuting may be mind-numbingly dull, but new research shows that it might also be having an adverse effect on both your health and performance at work. Longer commutes also appear to have a significant impact on mental wellbeing, with those commuting longer 33 per cent more likely to suffer from depression

Shutterstock

It is not possible to be overweight and healthy, a major new study has concluded. The study of 3.5 million Britons found that even metabolically healthy obese people are still at a higher risk of heart disease or a stroke than those with a normal weight range

Getty

When you feel particularly exhausted, it can definitely feel like you are also lacking in brain capacity. Now, a new study has suggested this could be because chronic sleep deprivation can actually cause the brain to eat itself

Shutterstock

David Lloyd Gyms have launched a new health and fitness class which is essentially a bunch of people taking a nap for 45 minutes. The fitness group was spurred to launch the napercise class after research revealed 86 per cent of parents said they were fatigued. The class is therefore predominantly aimed at parents but you actually do not have to have children to take part

Getty

Tobacco and alcohol companies could win more easily in court cases such as the recent battle over plain cigarette packaging if the EU Charter of Fundamental Rights is abandoned, a barrister and public health professor have said

Getty

A major new study into the side effects of the cholesterol-lowering medicine suggests common symptoms such as muscle pain and weakness are not caused by the drugs themselves

Getty

New research has found that babies born to fathers under the age of 25 or over 51 are at higher risk of developing autism and other social disorders. The study, conducted by the Seaver Autism Center for Research and Treatment at Mount Sinai, found that these children are actually more advanced than their peers as infants, but then fall behind by the time they hit their teenage years

Getty

Commuters who swap their car or bus pass for a bike could cut their risk of developing heart disease and cancer by almost half, new research suggests but campaigners have warned there is still an urgent need to improve road conditions for cyclists.Cycling to work is linked to a lower risk of developing cancer by 45 per cent and cardiovascular disease by 46 per cent, according to a study of a quarter of a million people.Walking to work also brought health benefits, the University of Glasgow researchers found, but not to the same degree as cycling.

Getty

Scientists conducted the research on 71 car crash victims as they were waiting for treatment at one hospitals accident and emergency department. They asked half of the patients to briefly recall the incident and then play the classic computer game, the others were given a written activity to complete. The researchers, from Karolinska Institute in Sweden and the University of Oxford, found that the patients who had played Tetris reported fewer intrusive memories, commonly known as flashbacks, in the week that followed

Rex

Thousands of 999 patients in England are being told to get a taxi to hospital, figures have showed. The number of patients outside London who were refused an ambulance rose by 83 per cent in the past year as demand for services grows

Getty

A vaping-related lung disease has claimed the lives of 11 people in the US in recent weeks. The US Centre for Disease Control and Prevention has more than 100 officials investigating the cause of the mystery illness, and has warned citizens against smoking e-cigarette products until more is known, particularly if modified or bought off the street

Getty

Researchers in the US claim to have overcome one of the major hurdles to cultivating human follicles from stem cells. The new system allows cells to grow in a structured tuft and emerge from the skin

Sanford Burnham Preybs

A study in the journal Scientific Reports suggests that a dose of nature of just two hours a week is associated with better health and psychological wellbeing

Shutterstock

Exposure to air from traffic-clogged streets could leave women with fewer years to have children, a study has found. Italian researchers found women living in the most polluted areas were three times more likely to show signs they were running low on eggs than those who lived in cleaner surroundings, potentially triggering an earlier menopause

Getty/iStock

Junk food adverts on TV and online could be banned before 9pm as part of Government plans to fight the "epidemic" of childhood obesity.Plans for the new watershed have been put out for public consultation in a bid to combat the growing crisis, the Department of Health and Social Care (DHSC) said

PA

On migrating from Africa around 70,000 years ago, humans bumped into the neanderthals of Eurasia. While humans were weak to the diseases of the new lands, breeding with the resident neanderthals made for a better equipped immune system

PA

The breath biopsy device is designed to detect cancer hallmarks in molecules exhaled by patients

Continue reading here:
What are the laws for sperm donation in the UK? - The Independent

It’s OK for dead men to donate their sperm, according to medical ethics study – Yahoo Lifestyle

A new study argues that men should be allowed to donate sperm to strangers after their death.

The January 20 study in the Journal of Medical Ethics raises similarities to organ donation, which allows people to donate life-saving tissue to those in need of transplants. If it is morally acceptable that individuals can donate their tissues to relieve the suffering of others in life-enhancing transplants for diseases, wrote the study authors, we see no reason this cannot be extended to other forms of suffering like infertility, which may or may not also be considered a disease.

The study suggests that allowing men to donate after death would help address the U.K. sperm donor shortage: between 2011 and 2013, the average number of newly-registered sperm donors per year was 586 (an increase of about 300 from 2004). But a portion of that increase also reflects donations used directly by mens partners, not strangers.

Postmortem sperm can be collected after death through surgery (by extracting sperm through a cut in the scrotum) or electroejaculation, aprocedure that delivers electric shocks to the prostate and stimulates ejaculation. Collected sperm would be cryopreserved in fertility clinics and thawed when ready for use.

Sperm harvesting after death has been technically possible for many years, and there is evidence that it can be used in reproduction, wrote the study authors. Case series have demonstrated that sperm retrieved from dead men can result in a viable pregnancies and healthy children, even when retrieved 48 hours after death.

Study co-author Joshua Parker, an education fellow in ethics and law at Wythenshawe Hospital in Manchester, England, tells Yahoo Lifestyle: Were suggesting that men could voluntarily donate their sperm to fertility clinics to alleviate pain for those suffering from infertility. But it raises ethical questions what preferences should people have when choosing donors? Whats the psychological impact on a child knowing that he or she was born from a deceased donor? And how does postmortem sperm donation affect grieving families and their relationship with a potential child?

Organ transplants benefit recipients with conditions that are life-threatening or life-enhancing, says the study, pointing to corneal transplants as an example of the latter. Infertility is not life-threatening, however, wrote the authors. There is also debate over whether infertility is a disease,which we cannot settle here and so will set aside. Nevertheless, as we argue below, infertility certainly causes suffering, some of which can be ameliorated by access to donor sperm....

Standards for postmortem sperm donations should equal those applied to living donations, says Parker, with quality of sperm being a high priority. However, that speaks to the quality of consent, he adds. Men would need to be aware of the possibility that their donations may not result in a pregnancy after they die.

A spokesperson from the Human Fertilization and Embryology Authority, which regulates fertility clinics in the U.K., did not return Yahoo Lifestyles request for comment. A spokesperson told CNN that donors must be medically screened, counseled and give consent. "None of these requirements could be satisfied if donation was only undertaken after death. Essentially, this means that harvesting sperm from a donor after death is currently illegal," the spokesperson said.

Some might feel that using sperm from a dead person is disturbing, a notion acknowledged by Parker. But we dont decide whats right or wrong based on that gut reaction, he tells Yahoo Lifestyle. Medical ethics are determined by reason, argument and evidence not whether we feel sick about it.

Read more from Yahoo Lifestyle:

Follow us onInstagram,FacebookandTwitterfor nonstop inspiration delivered fresh to your feed, every day.

Read the original here:
It's OK for dead men to donate their sperm, according to medical ethics study - Yahoo Lifestyle

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases – P&T Community

SECAUCUS, N.J. and HELSINKI, Finland, Jan. 22, 2020 /PRNewswire/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity transaction. Blueprint Genetics is a leading specialty genetic testing company with deep expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development. Financial terms of the transaction were not disclosed.

"The great challengewithgenetic testingisgeneratingquality,actionable and broadly accessible insights from vast quantities of sequenced genetic data," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "Blueprint Genetics has developed a proven modelfor deliveringhighly specializedgenetic insightsthat we believe we can scale toservenew patient populations with unmet clinical needs.The addition of Blueprint Geneticsstrengthensand extends the Questvalue proposition ingenetics,delivering on our Accelerate growth strategyand vision of a healthier world."

Founded in 2012, Blueprint Genetics grew rapidly, and now serves customers in over 70 countries. The company's growth is based largely on proprietary guideline-supported methods of gene variant interpretation of data generated from next generation sequencing, backed by high-touch consultative service. The company provides 3,900 targeted single gene and over 200 panel tests spanning 14 medical specialties. Gene variant interpretation involves identifying associations between gene variants and disease or treatment response.

Blueprint Genetics has increased its focus and presence in the United States through a recently established hub facility in Seattle, Washington. The acquisition provides a platform for Blueprint Genetics to leverage Quest's capabilities in next generation sequencing and national infrastructure serving half the health systems and physicians in the United States. Blueprint Genetics is expected to continue to operate largely independently from its base laboratory in Helsinki, Finland, and a presence in other countries.

Through its Advanced Diagnostics offerings, Quest specializes in combining state-of-the-art technologies, such as next generation sequencing, with higher-order interpretative expertise and digital customer enablement. Blueprint Genetics brings to Quest high-touch service in variant interpretation and reporting and associated sequencing and bioinformatics, which complement and extend its existing genetics leadership.

"As the leader in Advanced Diagnostics, Quest Diagnostics understands that robust bioinformatics and consultative expertise are essential to fast, accurate and cost-efficient data interpretation," said Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, Quest Diagnostics. "Blueprint Genetics brings to Quest a proven platform in specialty genetics -- especially gene variant interpretation and reporting -- that powerfully differentiates our Advanced Diagnostics offering."

Over time, the acquisition is expected to yield new capabilities to serve providers specializing in rare disease and neurology, particularly pediatric and academic hospitals. The two organizations also envision that members of the Quest Diagnostics Global Diagnostic Network and its pharmaceutical and in vitro diagnostic collaborators will benefit from Blueprint Genetics' capabilities.

"Blueprint Genetics prides itself on resolving the most challenging genetic and rare disease cases to improve patient outcomes," said TommiLehtonen, who has agreed to continue to lead the company as Vice President and General Manager, reporting to Ms. Eglinton Manner. "Teaming up with Quest will allow us to extend our capabilities in the United States as well as in Canada and other countries where we already have strong and growing client relationships. While we considered joining forces with several organizations, Quest's genetics leadership, national infrastructure and strong cultural fit made it the perfect partner from which to extend our reach to new providers and patients."

Genetic testing can aid in diagnosing many rare diseases as well as identifying future risk of and treatment for certain cancers and other conditions. According to the National Institutes of Health, as many as 7,000 rare diseases exist and as many as 30 million Americans have a rare disease.

About Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

View original content:http://www.prnewswire.com/news-releases/quest-diagnostics-acquires-blueprint-genetics-to-broaden-access-to-actionable-insights-for-genetic-and-rare-diseases-300990571.html

SOURCE Quest Diagnostics

Originally posted here:
Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases - P&T Community

David Hogness, Revolutionary of 20th Century Genetics, Dies – The Scientist

David Hogness

courtesy stanford medicine

David Hogness, a biochemist, geneticist, and developmental biologist at Stanford University, died at his home on December 24. He was 94 years old.

Hogness is well known for a series of experiments during the 1970s and 1980s that were instrumental in launching both molecular genetics and genomics, according to a university statement.

His lab brought molecular biology to Drosophila, discovered the first core promotor element in eukaryotes, cloned the Hox genes, studied the basis of steroid hormone signaling, the list goes on and on. He was a giant, says biologist Mark Peifer of the University of North Carolina in a tweet.

Hogness was born in Oakland, California, on November 17, 1925, and grew up in Chicago. In 1949, he received his bachelors degree in chemistry from Caltech, where he also earned his PhD in biology and chemistry in 1952.

While a faculty member at Washington University in St. Louis, Hogness studied bacteriophage lambda and created the first physical maps of genes along DNA, according to the statement. He joined Stanfords newly formed biochemistry department in 1959, and during a sabbatical in 1968, shifted his focus to Drosophila.

In a 1972 grant proposal, Hogness described the concept of chromosomal walkingnow known as positional cloninga technological breakthrough that many consider to be the founding of genomics, according to Stanfords statement.Hognesss 1975 paper published in PNAS detailed colony hybridization, a novel method of isolating cloned DNA. Three years later, Hogness discovered the Goldberg-Hogness box, now called the TATA box, a non-coding promoter sequence where transcription is initiated in archaea and eukaryotes (prokaryotes have a homolog called the Pribnow box). Another landmark study published in the early 1980s demonstrated the ability to clone the gene underlying any genetic trait, and simultaneously proved there were genes specifically devoted to regulating normal development, says Richard Lifton, the president of Rockefeller University and a former student of Hogness, in the press release. Its one of the great papers in the history of biology.

Daves genius was to realize that the recombinant DNA technologies newly developed at Stanford, which allowed researchers to isolate and replicate to very high copy numbers distinct segments of DNA, could be used to map the locations of the DNA segments to specific bands on the polytene chromosomes, developmental biologist Philip Beachy says in the statement.

Hognesss awards include the March of Dimes Prize in Developmental Biology in 1997, the Lifetime Achievement Award of the Society for Developmental Biology in 2002, the Thomas Hunt Morgan Medal in 2003, and the Warren Alpert Foundation Prize in 2013.

Hogness is survived by his sons.

Amy Schleunes is an intern atThe Scientist. Email her ataschleunes@the-scientist.com.

Read the original here:
David Hogness, Revolutionary of 20th Century Genetics, Dies - The Scientist

Seattle Genetics Up More Than 40% in the Past Year: Here’s Why – Yahoo Finance

Shares of Seattle Genetics, Inc. SGEN have surged 48% in the past year against the industrys decline of 3.5%.

Solid performance of its lead marketed drug Adcetris and the recent approval of Padcev (enfortumab vedotin-ejfv) might have been driving the stock price of late. Other pipeline candidates are also making good progress.

Adcetris is approved for relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma (sALCL) in the United States, the EU and Japan. The drug generated sales of $461.5 million in the first nine months of 2019, reflecting a year-over-year surge of 34%.

Improved sales of the drug were owing to its label expansions for frontline CD30-expressing PTCL and frontline HL.

In December 2019, the FDA granted accelerated approval to Padcev for the treatment of patients with advanced/metastatic urothelial cancer, who had received treatment with both a checkpoint inhibitor (PD-1/PD-L1) and platinum-based chemotherapy.

Following this nod, Padcev became the first FDA approved drug for treating the given patient population.

Notably, the nod came much before the scheduled Prescription Drug User Fee Act (PDUFA) action date of Mar 15, 2020. The company is developing Padcev in collaboration with Japanese partner Astellas Pharma, Inc.

The approval for Padcev should reduce Seattle Genetics heavy dependence on Adcetris and significantly boost its top line in the future quarters.

Apart from Adcetris and Padcev, the companys other antibody-drug conjugate (ADC) candidates including tucatinib, tisotumab vedotin, ladiratuzumab vedotin and SEA-BCMA are progressing well.

Notably, last month, Seattle Genetics and Astellas signed a collaboration agreement with pharma giant Merck MRK to begin a phase III study on the combination of Padcev and the latters PD-1/L1 inhibitor Keytruda (pembrolizumab) to address patients with previously untreated metastatic urothelial cancer.

Also, in the same period, Seattle Genetics submitted a new drug application (NDA) to the FDA for its oral tyrosine kinase inhibitor tucatinib in combination with Roche's RHHBY Herceptin (trastuzumab) and Xeloda (capecitabine). The company is seeking approval for tucatinib combo to treat patients with locally advanced/metastatic HER2-positive breast cancer including those with brain metastases who have received at least three prior HER2-directed agents separately or in combination in the neoadjuvant, adjuvant or metastatic setting.

However, sole reliance on Adcetris, which constitutes majority of the company's top line, remains a concern. It is also to be seen whether the newly-approved Padcev is able to make an impact and drive revenues in the long run.

Seattle Genetics, Inc. Price

Seattle Genetics, Inc. Price

Seattle Genetics, Inc. price | Seattle Genetics, Inc. Quote

Zacks Rank & Key Pick

Seattle Genetics currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the biotech sector is Epizyme, Inc. EPZM, which sports a Zacks Rank #1 (Strong Buy). You can seethe complete list of todays Zacks #1 Rank stocks here.

Epizymes loss per share estimates have narrowed 2.5% for 2020 over the past 60 days. The stock has skyrocketed 179.5% in the past year.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, its expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportMerck & Co., Inc. (MRK) : Free Stock Analysis ReportRoche Holding AG (RHHBY) : Free Stock Analysis ReportEpizyme, Inc. (EPZM) : Free Stock Analysis ReportSeattle Genetics, Inc. (SGEN) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

See original here:
Seattle Genetics Up More Than 40% in the Past Year: Here's Why - Yahoo Finance

Red Angus Genetics – AG INFORMATION NETWORK OF THE WEST – AGInfo Ag Information Network Of The West

Its so funny how good things can occur if you keep your ears open. The other night I was at the butcher counter in a local grocery store when I overheard two people talking about issues involving beef packaging and marketing. It turns out that one of them, named Logan Peters works for Agribeef in Boise and the other named Katie Ochsner is a marketing specialist for the Red Angus Association. We had a nice chat and I asked Katie specifically what she did. This time of year, our marketing team is traveling to a lot of bull sales which we attend all over the United States in order to promote our marketing programs. We generally give a pre-sale speech and then just interact with the commercial producers that are there buying in order to inform them about how they can use red Angus genetics in combination with our marketing programs to bring premiums for their calves. We have an age source and genetics verification program called the feeder calf certification program. As long as they are using registered bulls and the calves are at least 50% red Angus genetics, they can qualify for that program.

Read the original post:
Red Angus Genetics - AG INFORMATION NETWORK OF THE WEST - AGInfo Ag Information Network Of The West